Health Care
(E99)
990 on File
CURREN FOUNDATION FOR THE DIAGNOSIS & TREATMENT OF NEURO-ONCOLOGICAL
Financial strength (30%)
59/100
Reliability (20%)
45/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$77K
Total Revenue
$83K
Total Expenses
$3K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
0.41x
Liability-to-Asset
0.0%
Revenue Diversification
100.0%
Compared with Peers
FY 2024
Compared with 3,338 similar organizations
(United States, Health Care, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 81.7% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.4 mo | 26.5 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 99.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
52.2% | 0.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-10.4% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.3% | 16.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $77K | $83K | $3K | 100.0% | — |
| 2023 | $51K | $92K | $8K | 94.8% | — |
| 2022 | $62K | $117K | $50K | 82.4% | — |
| 2020 | $107K | $119K | N/A | — | 4 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.